Creating frog heart as an organ: in vitro-induced heart functions as a circulatory organ in vivo

被引:6
作者
Kinoshita, Masayoshi [2 ,3 ]
Ariizumi, Takashi [1 ]
Yuasa, Shinsuke [2 ,3 ]
Miyoshi, Shunichirou [3 ]
Komazaki, Shinji [4 ]
Fukuda, Keiichi [2 ]
Asashima, Makoto [1 ,5 ]
机构
[1] Univ Tokyo, Dept Life Sci Biol, Grad Sch Arts & Sci, Tokyo, Japan
[2] Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Tokyo, Japan
[3] Keio Univ, Sch Med, Div Cardiol, Dept Internal Med, Tokyo, Japan
[4] Saitama Med Sch, Dept Anat, Saitama, Japan
[5] Natl Inst Adv Ind Sci & Technol, Organ Dev Res Lab, Ibaraki, Japan
关键词
activin; animal cap; cardiogenesis; organ engineering; Xenopus laevis; LEFT-RIGHT ASYMMETRY; STEM-CELLS; UNDIFFERENTIATED CELLS; INDUCTION; CARDIOGENESIS; XENOPUS; DIFFERENTIATION; CARDIOMYOCYTES; SYSTEM; MODEL;
D O I
10.1387/ijdb.093036mk
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cardiomyocytes have been induced from various pluripotent cells, such as embryonic stem cells and myeloid stem cells; however, the generation of cardiac tissues beyond two-dimensional cell-sheets has not been reported. Creating higher order, three-dimensional structures that are unique to heart is the long-awaited next step in realizing cardiac regenerative medicine. We have previously shown that cardiomyocytes can be induced in vitro from undifferentiated cells (animal caps) excised from Xenopus embryos. Cardiomyocytes were induced by first dissociating the animal caps and then reaggregating them following treatment with activin. Here, we describe an interesting method for creating a complete ectopic heart in vivo, involving the introduction of in vitro-created tissue during early embryogenesis. Thus, animal cap reaggregates were transplanted into the abdomen of late-neurula-stage embryos, resulting in two-chambered hearts being formed. The dual-heart larvae matured into adult animals with transplanted hearts intact. Involvement of transplanted hearts in systemic circulation was demonstrated. Moreover, the ectopic hearts possessed higher order structures such as atrium and ventricle, and were morphologically, histologically, and electrophysiologically identical to original hearts. This system should facilitate the study of heart organogenesis and may promote a shift from tissue to organ engineering for clinical applications.
引用
收藏
页码:851 / 856
页数:6
相关论文
共 50 条
  • [41] Generation of robust vascular networks from cardiovascular blast populations derived from human induced pluripotent stem cells in vivo and ex vivo organ culture system
    Kawamoto, Tatsuya
    Kobayashi, Yoshifumi
    Nakajima, Hidenori
    Yamagishi, Yukiko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 441 (01) : 180 - 185
  • [42] A Perfused In Vitro Model Of Embryonic Heart Tube: Leveraging 3D Bioprinting And Human Induced Pluripotent Stem Cell Technologies To Study Heart Development
    Jin, Linqi
    Tomov, Martin L.
    Chen, Huang
    Avazmohammadi, Reza
    Dasi, Lakshmi
    Heaton, Holly Bauser
    Serpooshan, Vahid
    CIRCULATION RESEARCH, 2023, 133
  • [43] Activation of Receptors δ (PPARδ) by Agonist (GW0742) may Enhance Lipid Metabolism in Heart both In Vivo and In Vitro
    Kuo, S. -C.
    Ku, P. -M.
    Chen, L. -J.
    Niu, H. -S.
    Cheng, J. -T.
    HORMONE AND METABOLIC RESEARCH, 2013, 45 (12) : 880 - 886
  • [44] Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ
    Mark, Ethan
    Goldsman, David
    Keskinocak, Pinar
    Sokol, Joel
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (06)
  • [45] Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro
    Nguyen, Deborah G.
    Funk, Juergen
    Robbins, Justin B.
    Crogan-Grundy, Candace
    Presnell, Sharon C.
    Singer, Thomas
    Roth, Adrian B.
    PLOS ONE, 2016, 11 (07):
  • [46] In vitro and in vivo characteristics of connexin 43-modified human skeletal myoblasts as candidates for prospective stemcell therapy for the failing heart
    Kolanowski, T. J.
    Rozwadowska, N.
    Malcher, A.
    Szymczyk, E.
    Kasprzak, J. D.
    Mietkiewski, T.
    Kurpisz, M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 173 (01) : 55 - 64
  • [47] Predicting Stereoselective Disposition of Carvedilol in Adult and Pediatric Chronic Heart Failure Patients by Incorporating Pathophysiological Changes in Organ Blood Flows-A Physiologically Based Pharmacokinetic Approach
    Rasool, Muhammad Fawad
    Khalil, Feras
    Laeer, Stephanie
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (07) : 1103 - 1115
  • [48] Phenylephrine-Induced Cardiovascular Changes in the Anesthetized Mouse: An Integrated Assessment of in vivo Hemodynamics Under Conditions of Controlled Heart Rate
    Rajanathan, Rajkumar
    Pedersen, Tina Myhre
    Thomsen, Morten B.
    Botker, Hans Erik
    Matchkov, Vladimir V.
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [49] The protective effect of losartan against sorafenib induced cardiotoxicity: Ex-vivo isolated heart and metabolites profiling studies in rat
    Abdelgalil, Ahmed A.
    Mohamed, Osama Y.
    Ahamad, Syed Rizwan
    Al-Jenoobi, Fahad I.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 882
  • [50] Diabetes Warriors from Heart Wood: Unveiling Dalbergin and Isoliquiritigenin from Dalbergia latifolia as Potential Antidiabetic Agents in-vitro and in-vivo
    Sutrapu, Srinivas
    Pal, Rashmi Saxena
    Khurana, Navneet
    Vancha, Harish
    Mohd, Sharfuddin
    Chinnala, Krishna Mohan
    Kumar, Bimlesh
    Pilli, Govindaiah
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (02) : 1309 - 1324